2014
DOI: 10.1093/hmg/ddu264
|View full text |Cite
|
Sign up to set email alerts
|

Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer

Abstract: Genome-wide association studies (GWAS) of urinary bladder cancer (UBC) have yielded common variants at 12 loci that associate with risk of the disease. We report here the results of a GWAS of UBC including 1670 UBC cases and 90 180 controls, followed by replication analysis in additional 5266 UBC cases and 10 456 controls. We tested a dataset containing 34.2 million variants, generated by imputation based on whole-genome sequencing of 2230 Icelanders. Several correlated variants at 20p12, represented by rs6218… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
27
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 45 publications
(28 citation statements)
references
References 53 publications
0
27
0
Order By: Relevance
“…In particular, a high fraction of bladder carcinomas present deletion of the long arm of chromosome 9q, where NOTCH1 is located (39), and low levels of NOTCH1 and JAGGED1 are associated with short survival in bladder cancer patients (40). Even more, a genome-wide association study in patients with bladder cancer found a significant association with a SNP in a region near to JAGGED1, and carriers of this SNP showed a trend to have lower JAGGED1 expression, again suggesting a tumor-suppressive role for the NOTCH pathway (41). Following on these observations, our analyses of NOTCH mutations from bladder cancer patients, mouse genetic models, cellbased assays, and human cancer samples provide solid evidence that the canonical NOTCH pathway plays a relevant tumor-suppressive role in bladder cancer.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, a high fraction of bladder carcinomas present deletion of the long arm of chromosome 9q, where NOTCH1 is located (39), and low levels of NOTCH1 and JAGGED1 are associated with short survival in bladder cancer patients (40). Even more, a genome-wide association study in patients with bladder cancer found a significant association with a SNP in a region near to JAGGED1, and carriers of this SNP showed a trend to have lower JAGGED1 expression, again suggesting a tumor-suppressive role for the NOTCH pathway (41). Following on these observations, our analyses of NOTCH mutations from bladder cancer patients, mouse genetic models, cellbased assays, and human cancer samples provide solid evidence that the canonical NOTCH pathway plays a relevant tumor-suppressive role in bladder cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, genome-wide association studies (GWAS) have identified a subset of common variants associated with bladder cancer risk (5)(6)(7)(8)(9)(10)(11)(12)(13)(14). However, these studies have primarily been conducted in individuals of European descent, and only one GWAS reported by Matsuda and colleagues had been performed in Japanese (14).…”
Section: Introductionmentioning
confidence: 99%
“…It has also been established that genetics play an important role in risk of developing bladder cancer 3 . Recent genome-wide association studies have identified a total of at least 14 unique genetic loci that have a significant effect on bladder cancer risk in European-descent populations 415 . However, these risk factors only represent a small portion of the genetic basis of this disease suggesting that the full spectrum of genetic factors influencing risk of bladder cancer remains undetermined.…”
Section: Introductionmentioning
confidence: 99%